Research programme: human cytomegalovirus inhibitors - Wyeth
Alternative Names: Human cytomegalovirus inhibitors research programme - WyethLatest Information Update: 05 Oct 2006
At a glance
- Originator Wyeth
- Class
- Mechanism of Action Cytomegalovirus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 05 Oct 2006 Discontinued - Preclinical for Cytomegalovirus infections treatment in USA (unspecified route)
- 12 Feb 2002 Preclinical development for Cytomegalovirus infections in USA (Unknown route)